268 related articles for article (PubMed ID: 24503464)
1. The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer.
Sun Q; Zou X; Zhang T; Shen J; Yin Y; Xiang J
Gynecol Oncol; 2014 Mar; 132(3):730-8. PubMed ID: 24503464
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
Liu W; Lv C; Zhang B; Zhou Q; Cao Z
RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q; Guo R; Lin M; Zhou B; Wang Y
Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
5. [Overexpression of the receptor tyrosine kinase EphA2 in choroidal melanoma: correlation with vesculogenic mimicry and prognosis].
Chen LX; Sun BC; Li XR; He YJ; Song GX
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):985-90. PubMed ID: 23302271
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z
Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279
[TBL] [Abstract][Full Text] [Related]
9. miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene.
Tsouko E; Wang J; Frigo DE; Aydoğdu E; Williams C
Carcinogenesis; 2015 Sep; 36(9):1051-60. PubMed ID: 26088362
[TBL] [Abstract][Full Text] [Related]
10. Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma.
Kim HS; Won YJ; Shim JH; Kim HJ; Kim J; Hong HN; Kim BS
Sci Rep; 2019 Mar; 9(1):3414. PubMed ID: 30833656
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of miR-200a in chemosensitivity regulation of ovarian cancer].
Liu N; Zeng J; Zhang X; Yang Q; Liao D; Chen G; Wang Y
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(27):2148-51. PubMed ID: 25327865
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells.
Contreras-Sanzón E; Palma-Flores C; Flores-Pérez A; M Salinas-Vera Y; B Silva-Cázares M; A Marchat L; G Avila-Bonilla R; N Hernández de la Cruz O; E Álvarez-Sánchez M; Pérez-Plasencia C; D Campos-Parra A; López-Camarillo C
Cancer Biomark; 2022; 35(1):47-56. PubMed ID: 35662106
[TBL] [Abstract][Full Text] [Related]
14. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
Li J; Liang SH; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
[TBL] [Abstract][Full Text] [Related]
15. EphA2 expression is associated with aggressive features in ovarian carcinoma.
Thaker PH; Deavers M; Celestino J; Thornton A; Fletcher MS; Landen CN; Kinch MS; Kiener PA; Sood AK
Clin Cancer Res; 2004 Aug; 10(15):5145-50. PubMed ID: 15297418
[TBL] [Abstract][Full Text] [Related]
16. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
17. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNA-26b in glioma development and its mediated regulation on EphA2.
Wu N; Zhao X; Liu M; Liu H; Yao W; Zhang Y; Cao S; Lin X
PLoS One; 2011 Jan; 6(1):e16264. PubMed ID: 21264258
[TBL] [Abstract][Full Text] [Related]
19. MiR-200a promotes cell invasion and migration of ovarian carcinoma by targeting PTEN.
Suo HB; Zhang KC; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4080-4089. PubMed ID: 30024595
[TBL] [Abstract][Full Text] [Related]
20. miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator.
Zhu CL; Gao GS
Asian Pac J Cancer Prev; 2014; 15(20):8595-601. PubMed ID: 25374174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
